GB201709441D0 - Dosage regime - Google Patents
Dosage regimeInfo
- Publication number
- GB201709441D0 GB201709441D0 GBGB1709441.8A GB201709441A GB201709441D0 GB 201709441 D0 GB201709441 D0 GB 201709441D0 GB 201709441 A GB201709441 A GB 201709441A GB 201709441 D0 GB201709441 D0 GB 201709441D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- dosage regime
- regime
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1709441.8A GB201709441D0 (en) | 2017-06-14 | 2017-06-14 | Dosage regime |
AU2018285455A AU2018285455A1 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-CD25 ADC |
EP18732040.3A EP3638372A1 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-cd25 adc |
BR112019026498-1A BR112019026498A2 (en) | 2017-06-14 | 2018-06-14 | dosing regimens for administration of an anti-cd25 adc |
PCT/EP2018/065862 WO2018229218A1 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-cd25 adc |
CA3064681A CA3064681A1 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-cd25 adc |
US16/622,663 US11426467B2 (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-CD25 ADC |
MX2019014923A MX2019014923A (en) | 2017-06-14 | 2018-06-14 | Dosage regimes for the administration of an anti-cd25 adc. |
JP2019569364A JP2020523384A (en) | 2017-06-14 | 2018-06-14 | Dosing regimen for administering anti-CD25 ADC |
KR1020207001219A KR20200028950A (en) | 2017-06-14 | 2018-06-14 | Dosage regime for administration of anti-CD25 ADC |
US17/812,950 US20230039868A1 (en) | 2017-06-14 | 2022-07-15 | Dosage regimes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1709441.8A GB201709441D0 (en) | 2017-06-14 | 2017-06-14 | Dosage regime |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201709441D0 true GB201709441D0 (en) | 2017-07-26 |
Family
ID=59358153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1709441.8A Ceased GB201709441D0 (en) | 2017-06-14 | 2017-06-14 | Dosage regime |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201709441D0 (en) |
-
2017
- 2017-06-14 GB GBGB1709441.8A patent/GB201709441D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201713653D0 (en) | Dosage regimen | |
GB201709652D0 (en) | Pharmaceutical compounds | |
GB201704965D0 (en) | Pharmaceutical compounds | |
GB201704714D0 (en) | Pharmaceutical compounds | |
GB201703881D0 (en) | Pharmaceutical compounds | |
IL269239A (en) | Pharmaceutical combination comprising ponesimod | |
GB201521217D0 (en) | Dosage regimens | |
GB201706806D0 (en) | Pharmaceutical compounds | |
GB201703876D0 (en) | Pharmaceutical combinations | |
GB201704966D0 (en) | Pharmaceutical compounds | |
PL3515413T3 (en) | Extended relief dosage form | |
IL269169A (en) | Novel dosage form | |
GB201607548D0 (en) | Solid dosage form | |
GB201720543D0 (en) | Dosage regime | |
GB201720544D0 (en) | Dosage regime | |
GB201720542D0 (en) | Dosage regime | |
GB201720541D0 (en) | Dosage regime | |
GB201710496D0 (en) | Dosage regime | |
GB201710495D0 (en) | Dosage regime | |
GB201710494D0 (en) | Dosage regime | |
GB201710493D0 (en) | Dosage regime | |
GB201709441D0 (en) | Dosage regime | |
GB201709444D0 (en) | Dosage regime | |
GB201709440D0 (en) | Dosage regime | |
GB201709439D0 (en) | Dosage regime |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |